Page last updated: 2024-11-04

temozolomide and Barrett Esophagus

temozolomide has been researched along with Barrett Esophagus in 1 studies

Barrett Esophagus: A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jammula, S1
Katz-Summercorn, AC1
Li, X1
Linossi, C1
Smyth, E1
Killcoyne, S1
Biasci, D1
Subash, VV1
Abbas, S1
Blasko, A1
Devonshire, G1
Grantham, A1
Wronowski, F1
O'Donovan, M1
Grehan, N1
Eldridge, MD1
Tavaré, S1
Fitzgerald, RC1

Other Studies

1 other study available for temozolomide and Barrett Esophagus

ArticleYear
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
    Gastroenterology, 2020, Volume: 158, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Barrett Esophagus; Cyclin E; Disease Progression; DNA M

2020